FOXO TECHNOLOGIES INC.

FOXO Technologies Inc. (NYSE American: FOXO) is an insurtech company that completed its SPAC business combination in September 2022 through a merger with CF Acquisition Corp. VIII, a blank-check vehicle sponsored by Cantor Fitzgerald. The target SPAC conducted its IPO in 2021 and operated within the financial services and insurance technology sector. FOXO's core focus is applying epigenetic biomarker science to life insurance underwriting, positioning genomic and biological age data as a tool for risk assessment. The company's 8-K filed September 15, 2022 corresponds to the closing of that transaction and FOXO's debut as a publicly traded entity. Sign up at SpacDesk for complete filing timelines, sponsor details, and post-merger performance data on FOXO and hundreds of other SPAC transactions.